Annual ROE
-31.34%
+9.73%+23.69%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual return on equity is -31.34%, with the most recent change of +9.73% (+23.69%) on December 31, 2023.
- During the last 3 years, ALDX annual ROE has risen by +31.77% (+50.34%).
- ALDX annual ROE is now -130.76% below its all-time high of 101.87%, reached on December 31, 2011.
Performance
ALDX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-43.01%
-9.68%-29.04%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly return on equity is -43.01%, with the most recent change of -9.68% (-29.04%) on September 30, 2024.
- Over the past year, ALDX quarterly ROE has dropped by -9.24% (-27.36%).
- ALDX quarterly ROE is now -124.68% below its all-time high of 174.30%, reached on September 30, 2014.
Performance
ALDX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ALDX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.7% | -27.4% |
| 3 y3 years | +50.3% | -28.9% |
| 5 y5 years | +30.2% | +47.8% |
ALDX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -11.6% | +23.7% | -74.2% | at low |
| 5 y | 5-year | -11.6% | +75.2% | -74.2% | +59.0% |
| alltime | all time | -130.8% | +95.4% | -124.7% | +97.0% |
Aldeyra Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -43.01%(+29.0%) |
| Jun 2024 | - | -33.33%(+35.0%) |
| Mar 2024 | - | -24.69%(-16.2%) |
| Dec 2023 | -31.34%(-23.7%) | -29.45%(-12.8%) |
| Sep 2023 | - | -33.77%(-5.9%) |
| Jun 2023 | - | -35.88%(-8.0%) |
| Mar 2023 | - | -38.98%(+6.5%) |
| Dec 2022 | -41.07%(+46.3%) | -36.60%(+3.3%) |
| Sep 2022 | - | -35.42%(+5.8%) |
| Jun 2022 | - | -33.47%(+12.4%) |
| Mar 2022 | - | -29.78%(+1.2%) |
| Dec 2021 | -28.08%(-55.5%) | -29.43%(-11.8%) |
| Sep 2021 | - | -33.38%(-12.1%) |
| Jun 2021 | - | -37.99%(-25.1%) |
| Mar 2021 | - | -50.69%(-24.1%) |
| Dec 2020 | -63.11%(-50.1%) | -66.78%(-9.6%) |
| Sep 2020 | - | -73.85%(-26.8%) |
| Jun 2020 | - | -100.94%(-3.9%) |
| Mar 2020 | - | -105.01%(+5.6%) |
| Dec 2019 | -126.51%(+181.8%) | -99.40%(+20.8%) |
| Sep 2019 | - | -82.31%(+6.6%) |
| Jun 2019 | - | -77.23%(-3.4%) |
| Mar 2019 | - | -79.97%(-3.3%) |
| Dec 2018 | -44.90% | -82.67%(-17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -99.77%(+34.5%) |
| Jun 2018 | - | -74.17%(+4.7%) |
| Mar 2018 | - | -70.82%(+8.5%) |
| Dec 2017 | -56.41%(-34.7%) | -65.30%(-3.1%) |
| Sep 2017 | - | -67.42%(-16.1%) |
| Jun 2017 | - | -80.39%(+11.9%) |
| Mar 2017 | - | -71.81%(-6.5%) |
| Dec 2016 | -86.37%(+77.7%) | -76.81%(+5.0%) |
| Sep 2016 | - | -73.17%(+11.6%) |
| Jun 2016 | - | -65.59%(+16.1%) |
| Mar 2016 | - | -56.51%(+15.6%) |
| Dec 2015 | -48.60%(-41.1%) | -48.89%(-3.6%) |
| Sep 2015 | - | -50.69%(-14.0%) |
| Jun 2015 | - | -58.92%(-27.2%) |
| Mar 2015 | - | -80.92%(-9.4%) |
| Dec 2014 | -82.55%(-88.0%) | -89.33%(-151.3%) |
| Sep 2014 | - | 174.30%(-112.2%) |
| Jun 2014 | - | -1432.71%(+305.5%) |
| Mar 2014 | - | -353.35%(+84.9%) |
| Dec 2013 | -685.95%(-847.8%) | -191.11%(-296.2%) |
| Sep 2013 | - | 97.39%(-10.2%) |
| Jun 2013 | - | 108.47%(+6.1%) |
| Mar 2013 | - | 102.24%(+18.3%) |
| Dec 2012 | 91.73%(-10.0%) | 86.44% |
| Dec 2011 | 101.87% | - |
FAQ
- What is Aldeyra Therapeutics annual return on equity?
- What is the all time high annual ROE for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual ROE year-on-year change?
- What is Aldeyra Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly ROE year-on-year change?
What is Aldeyra Therapeutics annual return on equity?
The current annual ROE of ALDX is -31.34%
What is the all time high annual ROE for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual return on equity is 101.87%
What is Aldeyra Therapeutics annual ROE year-on-year change?
Over the past year, ALDX annual return on equity has changed by +9.73% (+23.69%)
What is Aldeyra Therapeutics quarterly return on equity?
The current quarterly ROE of ALDX is -43.01%
What is the all time high quarterly ROE for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly return on equity is 174.30%
What is Aldeyra Therapeutics quarterly ROE year-on-year change?
Over the past year, ALDX quarterly return on equity has changed by -9.24% (-27.36%)